Largest real-world data study finds tirzepatide (Mounjaro) up to three times more effective than semaglutide (Ozempic) for weight loss
In the first comparative effectiveness study of tirzepatide (Mounjaro) and semaglutide (Ozempic) for weight loss using real-world data, Truveta Research found that patients with overweight or…
Truveta announces availability of millions of echocardiogram reports to advance cardiovascular research
More than 50 organizations choose Truveta for the most complete, timely, and clean EHR data to study safety and effectiveness, improve patient care, and train medical AI
BELLEVUE, Wash. – October 23, 2023 – Truveta announced today that it is partnering with more than 50 organizations in life sciences, healthcare, government, academic medical…
Truveta advances security and privacy with Type 2 SOC 2 examination
Truveta has completed its Type 2 SOC 2 examination and continue to maintain ISO 27001 certifications, demonstrating the company’s relentless commitment to security, privacy, and trust.…
Partnership news: Truveta and Mathematica to advance public health and health equity with real-world data
Powerful partnership will allow researchers access to the most complete, timely, and clean health data to improve outcomes BELLEVUE, Wash. and PRINCETON, New Jersey – September…
Medical Components Inc. and Truveta partner to advance care for patients living with cancer and chronic kidney disease
Truveta Data will enable Medical Components, Inc. to study manufacturer-specific medical device data to address medical evidence gaps and improve clinical care recommendations. BELLEVUE, Wash. –…
Truveta Data now includes medication dispense data to help address nation’s 7th leading cause of death
With new medication dispense data – including prescription fill data from specialty pharmacies – Truveta Data offers even more complete, timely, and clean data to study…
Truveta community expands to more than 40 healthcare and life science organizations with a shared mission of saving lives with data
BELLEVUE, Wash. – May 17, 2023 – Today Truveta, a leader in electronic health record (EHR) data and analytics, announces the expansion of its community to…
JAMA Network Open publishes Truveta and Harvard University collaboration
New research published in JAMA Network Open shows changes in minoxidil prescribing following media attention about oral use for hair loss. BELLEVUE, Wash. – May 11,…
Truveta Language Model unlocks EHR data for the most complete and accurate medical research
Truveta’s clinical expert-led AI delivers the cleanest healthcare data, including structured concepts from clinician notes BELLEVUE, Wash. – April 12, 2023 – Today Truveta introduces the…
Truveta and Alpine Immune Sciences announce strategic partnership to access Truveta’s community to accelerate recruitment to povetacicept clinical trials
Truveta’s 28 health system members provide over 16% of patient care in the United States. BELLEVUE and SEATTLE, Wash. – March 21, 2023 – Today, Truveta…
New SDOH data in Truveta Studio provide most complete view of health equity’s influence on patient health and outcomes
Expanded de-identified social drivers of health data in Truveta Studio empower new health equity scenarios to study health disparities and improve patient care. BELLEVUE, Wash. –…
Truveta’s COVID-19 breakthrough infections research published in Vaccine
In a study of more than 1.2 million patients, new research shows the interaction effects of multiple comorbidities on the increased risk of COVID-19 breakthrough infections…
New research: Preeclampsia-related heart failure disproportionately impacts Black mothers
Among women with preeclampsia, new Truveta Research findings show that Black women are two times more likely to experience heart failure than white women. BELLEVUE, Wash.…
Truveta expands with three new US health system members
With 27 health system members, Truveta now includes de-identified patient journeys from all 50 US states. BELLEVUE, Wash. – January 24, 2023 – Three healthcare providers…
Truveta Research shares new insights on RSV hospitalization trends
New Truveta Research monitoring report shows rates of RSV hospitalizations compared to previous years, part of new research capabilities in Truveta Studio for ongoing disease monitoring.…
Truveta’s COVID-19 health equity research published in Frontiers in Public Health
New research published in Frontiers in Public Health shows racial disparities in COVID-19 hospitalization lengths of stay and access to treatments early in the pandemic. BELLEVUE,…
Truveta Studio delivers the health data and analytics the world deserves now
Truveta announces collaboration with Boston Scientific to advance post-procedure patient insights and help address healthcare disparities
Truveta welcomes four new health system members joining its vision of saving lives with data
WellSpan Health, Centura Health, MetroHealth, and Virtua Health join Truveta. BELLEVUE, Wash. – September 13, 2022 – Four leading healthcare providers — WellSpan Health, Centura Health,…
Truveta announces strategic collaboration with Pfizer to accelerate safety insights in real time
Real World Data on a grand scale empowers Pfizer to identify, monitor, and evaluate potential signals immediately using complete Electronic Medical Record data, updated daily for…
Truveta advances security and privacy with certification in ISO 27001, ISO 27701, ISO 27018 standards and Type 1 SOC 2 examination
BELLEVUE, Wash.– March 30, 2022 – Truveta, the health system-led company with a vision of saving lives with data, today announced that it has obtained an…
Truveta announces new COVID-19 insights and unveils Truveta platform for the first time at #ViVE2022
Those without boosters nearly two times more likely to get COVID-19 during Omicron surge, with greater risk for those with co-morbidities BELLEVUE, Wash.– March 8, 2022…
Truveta and LexisNexis Risk Solutions partner to advance health equity and health research quality
Linked de-identified data from both companies creates the most complete and highest quality living portrait of American public health to better improve all clinical research, understand…